New Horizon’s Sales Surge as China Promotes Early Cancer Detection
Company’s first-mover advantage in at-home colorectal screening and China’s focus on early detection have turbocharged sales, though valuation remains frothy Key takeaways: New Horizon’s first-half revenues jumped more than fourfold,…
RELATED ARTICLES
-
New Horizon Health finds formula for profits ahead of schedule
6606.HK
-
Sinking Burning Rock faces de-listing. But could privatization bid come first?
BNR.US
-
Burning Rock narrows losses with drug research as new driver
BNR.US
-
Fresh test for cancer-screening firm Genetron after Nasdaq exit
GTH.US
-
Sales success comes with side effects for drug maker BeiGene
BGNE.US 6160.HK
- FAST NEWS: Burning Rock’s cancer test gets breakthrough designation
-
EHang ready for takeoff?
EH.US
Discover hidden China stock gems in our weekly newsletter